Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

NCT05792033
Recruiting
Multicentric Prospective T1 Urinary Bladder Cancer Registry
Not applicable · Austria · 1 site
Registry update: 4 Apr 2023
NCT04895709
Recruiting
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/2 · Australia, Canada, Germany, Spain, Israel, Italy, Japan, United States · 47 sites
Registry update: 17 Aug 2026
NCT04724018
Recruiting
Sacituzumab Govitecan Plus EV in Metastatic UC
Phase 1/2 · United States · 1 site
Registry update: 4 Nov 2025
NCT05453682
Recruiting
Hypofractionated IMRT With Concurrent Chemotherapy in Muscle-invasive Bladder Cancer (HIRACUM)
Not applicable · South Korea · 1 site
Registry update: 2 Dec 2024
NCT04368702
Recruiting
CONFIRM: Magnetic Resonance Guided Radiation Therapy
Not applicable · United States · 2 sites
Registry update: 9 Feb 2026
NCT04892849
Recruiting
Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
Not applicable · Germany · 1 site
Registry update: 17 Sept 2025
NCT04900558
Recruiting
Robotic Radical Cystectomy Outcomes
Not applicable · Italy · 1 site
Registry update: 25 May 2021
NCT04724928
Recruiting
Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer
Phase 2 · Belgium · 1 site
Registry update: 15 Jan 2025
NCT04752722
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Phase 1/2 · Australia, Canada, Germany, Spain, France, United Kingdom, Italy, South Korea, Taiwan, United States · 105 sites
Registry update: 7 Aug 2026
NCT05739968
Recruiting
Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
Not applicable · Taiwan · 1 site
Registry update: 5 Jun 2024
NCT04693377
Recruiting
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Not applicable · United States · 1 site
Registry update: 15 Apr 2026
NCT04574960
Recruiting
Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)
Phase 3 · Canada · 2 sites
Registry update: 6 Oct 2026
NCT04532606
Recruiting
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
Phase 4 · China · 6 sites
Registry update: 30 Jul 2025
NCT04641936
Recruiting
Urine Omics Predicting IO Therapy Responses in mUC Patients
Not applicable · Taiwan · 1 site
Registry update: 17 Apr 2024
NCT03740256
Recruiting
Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · United States · 1 site
Registry update: 6 Feb 2026
NCT04503577
Recruiting
Prospective Bladder Cancer Infrastructure (ProBCI)
Not applicable · Netherlands · 23 sites
Registry update: 21 Sept 2026
NCT06116396
Recruiting
Liquid Biospy for Urinary Cancers
Not applicable · Italy · 1 site
Registry update: 7 Nov 2023
NCT04564781
Recruiting
Predicting BCG Response
Not applicable · Australia, Japan, United States · 6 sites
Registry update: 6 Jul 2026
NCT04235764
Recruiting
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
Not applicable · United States · 1 site
Registry update: 29 Oct 2026
NCT04442724
Recruiting
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
Not applicable · United States · 3 sites
Registry update: 14 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.